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Medical Applications of Synchrotron Radiation
edical applications of synchrotron radiation range from infra-red spectroscopy to X-ray imaging and radiation therapy. In this issue we have chosen to highlight programs in the hard X-ray energy range where the imaging and therapy can potentially be carried out in vivo and in a clinical environment.
Since the early coronary angiography programs based on K-edge digital subtraction, there have been significant advances in imaging techniques. Diffraction Enhanced Imaging, also called Analyser Based Imaging, and high resolution propagation phase contrast imaging have opened up new opportunities for clinical applications. Imaging of tissues and small animal anatomy are relevant for clinical diagnostics. One of the highlights of present activity is the in-vivo human mammography program at ELETTRA. It is always the goal of researchers in the field of medical applications to translate the technologies developed into the clinic. That remains both a cultural and engineering challenge.
Expectations are high that in the next few years studies at the Canadian Light Source and the Australian Synchrotron will move to human imaging studies. The properties of synchrotron radiation also make it an ideal tool for unique radiation therapy applications. The high dose rates and tunable energy spectrum have allowed the development of Synchrotron Stereotactic Radiotherapy and Microbeam Radiation Therapy. Both of these modalities are expected to reach clinical trials within the next couple of years at the ESRF.
It is an exciting time in which we are experiencing the culmination of several decades of development of medical imaging and therapy technologies at synchrotrons.■ M SRN Synchrotron Radiation News ISSN 0894-0886 is published bi-monthly. Coden Code: SRN EFR
